564
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Probiotics in the Management of Irritable Bowel Syndrome: A Review of Clinical Trials

Pages 212-216 | Published online: 11 Jul 2009

  • Report of American Gastroenterological Association Patient Care Committee. Irritable bowel syndrome: a technical review for practice guideline development Gastroenterology 1997; 112: 2120-37.
  • Akehurst R, Kaltenthaler E. Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut 2001; 48: 272-82.
  • Farthing MJG. Irritable bowel, irritable body, irritable brain? BrMed J 1995; 310: 171-5.
  • Hamilton-Miller JMT. The urethral syndrome and its management. J Antimicrob Chemother 1994; 33 (Suppl A): 63-73.
  • Gui X-Y. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol 1998; 13: 980-9.
  • Balsari A, Ceccarelli A, Dubini F, Fesce E, PoIi G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982; 5: 185-94.
  • Bayiiss CE, Houston AP, Alun-Jones V, Hishon S, Hunter JO. Microbiological studies on food intolerance. Proc Nutr Soc 1984; 43: 16A.
  • McKendrick MW, Read NW. Irritable bowel syndrome-post salmonella infection. J Infect 1994; 29: 1-3.
  • Gwee K-A, Leong Y-I, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-6.
  • Garcia Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Br Med J 1999; 318: 565-6.
  • Borody TJ, George L, Andrews P, et al. Bowel flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Australia 1989; 150: 604.
  • Pearce L, Bampton PA, Borody TJ, Shortis NP. Modification of the colonie microflora using probiotics: the way forward? Gut 1997; 41 (Suppl 3): A63.
  • Alun-Jones V, Wilson AJ, Hunter JO, Robinson RE. The aetiological role of antibiotic prophylaxis with hysterectomy in irritable bowel syndrome. J Obstet Gynaecol 1984; 5 (Suppl 1): S22-3.
  • Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-6.
  • King TS, Elia M, Hunter JO. Abnormal colonie fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-9.
  • Tannock GW (ed.). Probiotics: a Critical Review. Wymondham: Horizon Press, 1999.
  • Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130: 396S-402S.
  • Gade J, Thorn P. Paraghurt for patients with irritable bowel syndrome. Scand J Prim Health Care 1989; 7: 23-6.
  • Panijel M, Burkhard I. Pro-Symbioflor zur Behandlung des irritablen Kolons. Jatros Naturheilkunde 1993; 2 (3): 21-4.
  • Schaffstein W, Burkhard I. Symbioflor 2-eine therapeutische Alternative zur Behandlung des irritablen Kolons. Jatros Gastroenterol 1993; 2 (4): 24-6.
  • Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996; 91: 1579-85.
  • Hunter JO, Lee AJ, King TS, Barratt MEJ, Linggood MA, Blades JA. Enterococcus faecium strain PR88-an effective probiotic. Gut 1996; 38: A62suppl.
  • Young RJ, Vanderhoof JA. Successful probiotic therapy of chronic recurrent abdominal pain in children. Gastroenterology 1997; 112: A856.
  • Kordecki H, Niedzielin K. New possibility in the treatment of irritable bowel syndrome. Probiotics as a modification of the microflora of the colon. Gastroenterology 1998; 114: A402.
  • Nobaek S, Johansson M-L, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231-8.
  • De Simone C, Famularo G, Salvadore BB, et al. Treatment of irritable bowel syndrome (IBS) with the newer probiotic VSL # 3: a multicenter trial. Am J Clin Nutr 2001; 73 (Suppl 1): 491S.
  • Newcomer AD, Park HS, O'Brien PC, McGiIl DB. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Am J Clin Nutr 1983; 38: 257-63.
  • Hentschel C, Bauer J, Dill N, et al. Complementary medicine in non-ulcer-dyspepsia: is alternative medicine a real alternative? A randomised placebo-controlled double blind clinical trial with two probiotic agents (Hylac N and Hylac N Forte). Gastroenterology 1997; 112: A146.
  • Farthing MJG. Irritable bowel syndrome: new pharmaceutical approaches to treatment. Bailleres CliHn Gastroenterol 1999; 13: 461-71.
  • Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice. Can Med Assoc J 1999; 161: 154-60.
  • Jailwala J, Imperiale TF, Kroenke K. Pharmacological treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Int Med 2000; 133: 136-47.
  • Rothstein RD. Irritable bowel syndrome. Med Clin North Am 2000; 84: 1247-57.
  • Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
  • Rosenkranz W, Grundmann E. Immunomodulatorische Wirkung lebender nicht-pathogener Enterococcus faecalisBakterien des Menschen. Arzneimitt Forsch 1994; 44: 691-5.
  • McCracken VJ, Gaskins HR. Probiotics and the immune system. In: Tannock GW, ed. Probiotics. A Critical Review. Wymondham: Horizon Press, 1999: 85-111.
  • Hamilton-Miller JMT. Can probiotics products improve health? Pulse 2000; 60 (6): 53, 57.